These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 1125055)
41. In vitro and in vivo inhibition by benserazide of clorgyline-resistant amine oxidases in rat cardiovascular tissues. Lyles GA; Callingham BA Biochem Pharmacol; 1982 Apr; 31(7):1417-24. PubMed ID: 7092930 [TBL] [Abstract][Full Text] [Related]
42. Monoamine oxidase-III. Further studies of inhibition by propargylamines. Williams CH; Lawson J Biochem Pharmacol; 1975 Oct; 24(20):1889-91. PubMed ID: 1191339 [No Abstract] [Full Text] [Related]
43. Effect of clorgyline on trinitrobenzenesulfonic acid incorporation into mitochondrial membranes. Baker SP; Hemsworth BA Biochem Pharmacol; 1978; 27(19):2327-32. PubMed ID: 31883 [No Abstract] [Full Text] [Related]
44. On the dual nature of monoamine oxidase. Knoll J Horiz Biochem Biophys; 1978; 5():37-64. PubMed ID: 355087 [No Abstract] [Full Text] [Related]
45. [Interaction between clorgyline and reserpine on the arterial blood pressure on the spinal cat (author's transl)]. Galiana J; Alamo C; Cuenca E Arch Farmacol Toxicol; 1977 Aug; 3(2):109-16. PubMed ID: 921331 [No Abstract] [Full Text] [Related]
46. The effect of selective MAO inhibitors on the conditioned avoidance response of Wistar rats. Knoll B; Held G; Gyarmati Z Pol J Pharmacol Pharm; 1977; 29(3):291-6. PubMed ID: 887504 [TBL] [Abstract][Full Text] [Related]
47. The rational design of suicide substrates of amine oxidases. Palfreyman MG; McDonald IA; Bey P; Danzin C; Zreika M; Lyles GA; Fozard JR Biochem Soc Trans; 1986 Apr; 14(2):410-3. PubMed ID: 3086155 [No Abstract] [Full Text] [Related]
48. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity]. Severina IS; Klimova GI; Nersisian AA Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482 [TBL] [Abstract][Full Text] [Related]
49. Monoamine oxidase inhibitory properties of 5-hydroxymethyl-3-m-tolyloxazolidin-2-one (toloxatone). Kan JP; Malone A; Benedetti MS J Pharm Pharmacol; 1978 Mar; 30(3):190-2. PubMed ID: 24698 [No Abstract] [Full Text] [Related]
50. On the presence of a clorgyline resistant benzylamine oxidase activity in mouse kidney. Banchelli G; Buffoni F; Raimondi L Pharmacol Res Commun; 1988 Jun; 20(6):465-83. PubMed ID: 3138700 [TBL] [Abstract][Full Text] [Related]
51. The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formation. Braestrup C; Andersen H; Randrup A Eur J Pharmacol; 1975 Nov; 34(1):181-7. PubMed ID: 1241962 [TBL] [Abstract][Full Text] [Related]
52. A kinetic evaluation of monoamine oxidase activity in rat liver mitochondrial outer membranes. Houslay MD; Tipton KF Biochem J; 1974 Jun; 139(3):645-52. PubMed ID: 4850215 [TBL] [Abstract][Full Text] [Related]
53. Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Johnston JP Biochem Pharmacol; 1968 Jul; 17(7):1285-97. PubMed ID: 5659776 [No Abstract] [Full Text] [Related]
54. Impact of 2 doses of clorgyline on the rat preimplantation embryo development and the monoamine levels in urine. Mihalik J; Mašlanková J; Špakovská T; Mareková M; Hodorová I; Kušnír J; Rybárová S; Ferenc P; Schmidtová K Reprod Sci; 2010 Aug; 17(8):734-41. PubMed ID: 20595704 [TBL] [Abstract][Full Text] [Related]
55. Inhibition of central monoamine oxidase by imidazoline2 site-selective ligands. Lalies MD; Hibell A; Hudson AL; Nutt DJ Ann N Y Acad Sci; 1999 Jun; 881():114-7. PubMed ID: 10415906 [No Abstract] [Full Text] [Related]
56. The amine oxidase of human blood lymphocytes and granulocytes. Banchelli G; Fantozzi R; Ignesti G; Pirisino R; Raimondi L; Buffoni F Biochem Int; 1983 Jul; 7(1):89-94. PubMed ID: 6433929 [TBL] [Abstract][Full Text] [Related]
57. [Current status of type A and type B monoamine oxidase (author's transl)]. Suzuki O Seikagaku; 1980; 52(3):158-62. PubMed ID: 6774035 [No Abstract] [Full Text] [Related]
58. [Monoamine oxidase activity and gamma-aminobutyric acid levels in hyperoxia. The effect of clorgyline]. Goroshinskaia IA; Krichevskaia AA; Shugaleĭ VS; Sherstnev KB; Balamirzoeva RM Vopr Med Khim; 1986; 32(2):76-9. PubMed ID: 3705520 [TBL] [Abstract][Full Text] [Related]
59. The effect of repeated doses of (-) deprenyl on the dynamics of monoaminergic transmission. Comparison with clorgyline. Zsilla G; Földi P; Held G; Székely AM; Knoll J Pol J Pharmacol Pharm; 1986; 38(1):57-67. PubMed ID: 3020531 [TBL] [Abstract][Full Text] [Related]
60. The potentiating effect of clorgyline and pyrogallol on the blood pressure responses to norepinephrine. Lai FM; Spector S Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):279-86. PubMed ID: 708154 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]